key: cord-0940204-gim57whv
authors: Mak, S. M.; Mak, D.; Hodson, D.; Preston, R.; Retter, A.; Camporota, L.; Benedetti, G.
title: Pulmonary infarction without pulmonary arterial thrombus in COVID-19 patients receiving extracorporeal membrane oxygenation: a case series
date: 2020-07-19
journal: Clin Radiol
DOI: 10.1016/j.crad.2020.07.006
sha: 54f6c605b8ce290f322ac1cbbc4f7644022a57af
doc_id: 940204
cord_uid: gim57whv

Abstract Aim To evaluate the incidence of pulmonary ischaemia in COVID-19 patients on extracorporeal membrane oxygenation (ECMO), and its correlation with pulmonary artery thrombosis. Materials and methods Computed tomography (CT) thorax of patients receiving ECMO with proven COVID-19 pneumonitis between March and May 2020 were analysed for the presence and extension of pulmonary thromboembolic disease. Results Fifty-one patients were reviewed with a mean (range) age of 45 (26–66) years; 38/51 (74.5%) were men. All patients had severe COVID-19 pneumonitis, and 18/51 (35.3%) had macroscopic thrombosis (15 with associated ischaemia); however, 13/51 (25.5%) patients had ischaemia without associated thrombus. Conclusion The majority of patients with COVID-19 who received ECMO had areas of infarction within consolidated lungs, and almost half of these without subtending pulmonary artery thrombosis. Although the prognostic significance of these findings is unclear, they are highly suggestive of lung infarction due to isolated microvascular immune thrombosis.

RESULTS: Fifty-one patients were reviewed with a mean (range) age of 45 (26-66) years; 38/51 (74.5%) were men. All patients had severe COVID-19 pneumonitis, and 18/51 (35.3%) had macroscopic thrombosis (15 with associated ischaemia); however, 13/51 (25.5%) patients had ischaemia without associated thrombus.

CONCLUSION: The majority of patients with COVID-19 who received ECMO had areas of infarction within consolidated lungs, and almost half of these without subtending pulmonary artery thrombosis. Although the prognostic significance of these findings is unclear, they are highly suggestive of lung infarction due to isolated microvascular immune thrombosis.

Coronavirus disease 2019 (COVID-19) is a novel viral disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which was first detected in Wuhan, China, in December 2019 [1, 2] . The outbreak was declared a worldwide pandemic in March 2020.

COVID-19 patients can develop severe respiratory failure requiring invasive mechanical ventilation. Radiologically, this can present as an acute respiratory distress (ARDS)-like syndrome, associated with high mortality [3]; however, COVID-19 patients present with characteristic features due to angiogenesis and thrombotic complications due to a proinflammatory and hypercoagulable state [4, 5] . There is increasing literature documenting the prothrombotic state of COVID-19 patients, suggesting abnormally high levels of D-dimers associated with venous and pulmonary thromboembolism [6, 7, 8] . As there may be a microangiopathic component to the disease, small vessel occlusion and infarction may also occur.

It was postulated that these peculiar characteristics of COVID-19 could lead to pulmonary ischaemia due to microthrombosis. This may be more prevalent in severe disease, such as in patients who received extracorporeal membrane oxygenation (ECMO) due to severe and refractory acute hypoxaemic respiratory failure (AHRF).

The aim of this study was to report the prevalence and extent of microthrombotic lesions and pulmonary infarcts on contrast-enhanced computed tomography (CT) of the thorax in absence of visible pulmonary emboli (PE) in patients with AHRF on ECMO.

March and May 2020 were reviewed retrospectively by two cardiothoracic radiologists in consensus (7 and 9 years of experience, G.B. and S.M.M.). All patients tested positive for SARS-CoV-2 by RNA polymerase chain reaction on pharyngeal swab isolates. Main laboratory parameters at admission were collected.

CT images were reviewed to assess the presence and extension of PA filling defects and geographical areas of hypodense lung parenchyma on contrast-enhanced CT thorax. Their most proximal location was assessed as central, lobar, segmental, or subsegmental. Further distal extent of thrombus was graded as "mild" when there was involvement of a single lung parenchymal segment, "moderate" when involving between two and four segments, "extensive" when involving more than five segments. The attenuation of the main PA, size of the main PA, presence of right heart dilatation, presence and extension of ground-glass opacification (GGO) and dense consolidation (DC) were recorded. GGO and DC were graded with the same score as hypodense areas of lung parenchyma.

Data were collected from the first 51 patients with COVID-19 who received ECMO for refractory AHRF. The mean (range) age was 45 (26-66) years; 38 were men (74.5%). Patients had a variable prodrome from 1-4 weeks, with fever, cough, and malaise. Upon admission to the ECMO Unit, all patients received unfractionated heparin infusion as per the local ECMO protocol unless evidence of intracranial or uncontrolled extracranial bleeding was demonstrated by CT. Admission blood parameters are shown in Table 1 Twenty-eight of the 51 patients had wedge-shaped low-attenuation areas within the lung parenchyma (54.9%). When assessing the most proximal lung parenchymal involvement, 2/51 had lobar distribution (3.9%), 9/51 had segmental distribution (17.6%), and 17/51 had subsegmental distribution (33.3%). Of the two with lobar distribution, one had severe extent, one had moderate extent. Of the nine with segmental distribution, five had moderate extent, and four had mild extent. Of the 17 with subsegmental distribution, four had severe extent, 10 had moderate extent, three mild extent (Table 3 ).

Of the above 28 patients with low-attenuation areas within the lung parenchyma, 15 had concomitant pulmonary artery thrombus (53.6%), while the other 13 did not demonstrate visible thrombus (46.4%; Fig. 3 ). Three of the 18 patients (16.7%) with PA thrombus showed no hypodense lung parenchymal area (Table 4 ).

Only 12 patients had evidence of right heart dilatation (23.5%). The average (SD) diameter of the main PA was 27.37±3.89 mm (range 19-37 mm), and the aortopulmonary ratio was altered (<1) in 17 cases (33.3%).

All patients had widespread bilateral dense consolidations (100%). Forty-nine of the 51 patients had GGO changes (96.1%): two patients had no GGO (3.9%), five patients had an overall mild GGO involvement (9.8%), 10 patients moderate (19.6%), and 34 patients severe (66.7%).

The current study presents the CT thorax findings of 51 patients placed on ECMO due to severe COVID-19 hypoxaemic respiratory failure refractory to mechanical ventilation. There was a high prevalence of PA thrombus and a higher prevalence of multiple peripheral wedge-shaped low-attenuation areas within the lung parenchyma, the latter suggestive of pulmonary infarctions. Interestingly, nearly half of the patients with low-attenuation areas within the lung parenchyma did not demonstrate any visible subtending PA thrombus on CT. Although the pathological, clinical, and prognostic implications of these findings are not fully understood, it represents microvascular thrombosis in the absence of large thrombus within the pulmonary arterial tree in the setting of COVID-19-related immune thrombosis. The prothrombotic state described in patients with COVID-19 may be due to direct effects of the coronavirus or the associated hyperinflammatory state. "Immunothrombosis" is an increasingly popular term coined to describe this phenomenon. The common phrase "pulmonary embolus" should be replaced cautiously with "pulmonary thrombus" to avoid the impression that they are embolic. Although the optimal thromboprophylaxis in COVID-19 patients is still controversial, national societies have issued new guidance on thromboprophylaxis in COVID-19 patients, as the British Thoracic Society did for the UK [12] . These findings may have therapeutic implications in terms of short-to long-term anticoagulation.

The main limitation of this study is the absence of histological confirmation of radiological findings. In addition, all the patients presented in this paper showed extensive bilateral dependent dense consolidation with admixed extensive GGO on CT thorax, as expected in cases of severe COVID-19 pneumonitis. Therefore, the main findings of the paper regarding lung infarctions cannot be generalised to all patients with COVID-19 infection, but should be limited to the group affected by severe COVID-19 pneumonitis.

Further research is needed to investigate the outcome of patients with these radiological changes.

thoracic.org.uk/document-library/quality-improvement/covid-19/bts-guidanceon-venous-thromboembolic-disease-in-patients-with-covid-19/ (accessed ?????). 

Monitoring the COVID-19

Values are reported as median with interquartile ranges in brackets. Values are shown for all patients, patients without PA thrombus, with PA thrombus, patients without lung parenchymal ischaemia, patients with lung ischaemia and patients with neither PA thrombus nor lung ischaemia

Guarantor of integrity of the entire study SMM, RP 2 2. Study concepts and design SMM

Declaration of interests ☒ The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work

The authors acknowledge the radiographers and the Critical Care Department for their vital role during this pandemic.